Cargando…
Plasma concentrations of caspofungin in a critically ill patient with morbid obesity
Autores principales: | Ferriols-Lisart, Rafael, Aguilar, Gerardo, Pérez-Pitarch, Alejandro, Puig, Jaume, Ezquer-Garín, Carlos, Alós, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540490/ https://www.ncbi.nlm.nih.gov/pubmed/28764793 http://dx.doi.org/10.1186/s13054-017-1774-2 |
Ejemplares similares
-
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
por: Aguilar, Gerardo, et al.
Publicado: (2017) -
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019) -
Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation
por: Aguilar, Gerardo, et al.
Publicado: (2016) -
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020) -
Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
por: Märtson, Anne-Grete, et al.
Publicado: (2020)